Objectives: To compare the discriminative power of the five-level version of the EuroQol five-dimensional questionnaire (EQ-5D-5L [5L]) and its three-level version (EQ-5D-3L [3L]) in patients with diabetes in Singapore. Methods: A consecutive sample of patients with type 2 diabetes mellitus (T2DM) self-completed the two versions of the EQ-5D in the clinic. The 3L index score was calculated from the Singapore 3L value set, whereas the 5L index score was mapped from the 5L index score using an interim scoring. The discriminative power of the two EQ-5D indices was assessed in terms of their relative efficiency (RE) in differentiating patients with T2DM with and without one of eight clinical conditions. The efficiency of the two EQ-5D classification systems was evaluated using the Shannon's index (H') and in terms of ceiling effects. Results: A total of 121 patients with T2DM provided data for this study. The 3L score was systematically higher than the 5L score for patients with T2DM with a condition and systematically lower for the patients without a condition, with the mean differences being 0.005 and À0.011, respectively. The 5L index score showed higher RE in seven of eight clinical conditions (mean RE 1.87). The 5L classification system had higher H' in all dimensions: mobility (1.17 vs. 0.70), self-care (0.57 vs. 0.41), usual activities (1.01 vs. 0.72), pain/discomfort (1.47 vs. 1.02), and anxiety/depression (1.36 vs. 1.10). The overall ceiling effects decreased from 47.9% (3L) to 38.8% (5L). Conclusions: The EQ-5D-5L is more discriminative than the EQ-5D-3L in patients with T2DM in Singapore, supporting the use of EQ-5D-5L in the population.
Introduction
The three-level version of the EuroQol five-dimensional (EQ-5D) questionnaire (EQ-5D-3L [3L]), the original version of the EQ-5D, is a preference-based instrument that has been widely used to describe and value health [1] . It contains a health-state classification system and a value set [2] . The classification system defines health in five dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression), each dimension with three levels ("no problems" [level 1], "some problems" [level 2], and "extreme problems" [level 3]), resulting in a total of 243 (3 5 ) health states. The system can be used as a self-completion questionnaire by a respondent to classify his or her own health status. The value set assigns each health state defined by the system a single preference-based index score to indicate its utility to the general public [2] . Although the 3L has shown validity and reliability in patients with diabetes [3] , it may be insensitive to health difference in patients with minor problems and in those with multiple complications. It has also exhibited ceiling effects [4] [5] [6] .
A five-level version of the EQ-5D (the EQ-5D-5L [5L]) has been recently developed by the EuroQol Group [7] . The 5L expands the EQ-5D classification system by adding two more response options in each dimension. According to previous studies comparing the two versions of the EQ-5D in various populations [8] [9] [10] [11] [12] [13] [14] [15] , the 5L classification system can improve the discriminative power of health difference and decrease the ceiling effects. Most of the studies, however, did not compare the discriminative power of the two EQ-5D index scores, except for a study by Pan et al. [15] . This study compared the index scores in terms of their ability in distinguishing health severity levels among Chinese patients with diabetes, and indicated that the EQ-5D-5L index score is more discriminative. Given the possible variation in the health status of patients with diabetes, and the difference in preference to the EQ-5D health states in different countries [16] , a comparison of the two versions of the EQ-5D in patients with diabetes in other countries is still needed.
We therefore aimed to assess the ability of the two EQ-5D indices in discriminating patients with type 2 diabetes mellitus (T2DM) with different severity levels in Singapore.
Methods

Study Participants
This study was approved by the institutional review board of the National Healthcare Group of Singapore. In the study, consecutive outpatients with T2DM were recruited from the diabetes clinic of a tertiary hospital in Singapore in 2012. The following were the inclusion criteria for the patients: 1) must have a diagnosis of T2DM, 2) must be Singapore citizens/Singapore permanent residents aged 21years or older, and 3) must have the ability to read and converse in English.
Study Design
After their routine consultations in the clinic, consenting patients with T2DM were asked to self-complete a questionnaire including the two EQ-5D versions and sociodemographic and clinical questions. The clinical questions asked about the presence of diabetes complications (i.e., retinopathy, neuropathy, dermopathy, diabetic heart disease, diabetic cerebrovascular disease, peripheral vascular disease, diabetic foot ulcer, and lower extremity amputation) and comorbidities (e.g., lung disease, arthritis, depression/anxiety, cancer, and musculoskeletal disease). The questions were framed as follows: "Have you ever been told by a doctor that you had …?" The 5L was administered before the 3L because a previous study showed that study subjects tended to avoid the use of levels 2 and 4 of the 5L when the 3L was used first [13] . The patients' other clinical information (i.e., body mass index [BMI] and hemoglobin A 1c levels) was retrieved from their medical records. The patients were told that the 3L and the 5L were independent approaches for assessing their health. An investigator was available to assist the patients in completing the questionnaire if necessary.
Instruments
The 3L classification system defined the 243 health states by combining different levels from each dimension, with 11111 and 33333 representing full health and worst health, respectively. The 5L classification system comprised the same five dimensions, but each dimension included five levels: "no problem" (level 1), "slight problems" (level 2), "moderate problems" (level 3), "severe problems" (level 4), and "extreme problems" (level 5) [7] . Hence, the system defined 3125 (5 5 ) health states ranging from 11111 to 55555. The descriptors of levels 1, 3, and 5 in the 5L were similar but not identical to the wording of the 3L levels. For example, in the mobility dimension, the description "I am confined to bed" (level 3) in the 3L was changed to "I am unable to walk about" (level 5) in the 5L. The Singapore 3L value set was adopted to translate the patients' responses to the 3L index scores [17] ; an indirect interim mapping method was used to predict the preference scores of the 5L health states from the 3L scores [18] . The details of the method were reported elsewhere [18] . Briefly, the preference scores of the 5L health state were computed by summing the preference scores of the 3L health states weighted by the transition probability from the 3L state to the 5L state. The highest and the lowest scores for both the EQ-5D indices were 1.00 and À0.769, respectively.
Data Analysis
Redistribution Properties from the 3L to the 5L
We evaluated redistribution properties from the 3L to the 5L, defined as proportions of the 3L-5L response pairs in each 3L response level (i.e., 3L-1, 3L-2, and 3L-3) [13] . An inconsistent response pair was defined as a 3L response that was at least two levels away from the 5L response (e.g., level 1 [no problem] in the 3L, whereas level 3 [moderate problems] in the 5L); the other pairs were regarded as consistent. We calculated the proportion of each consistent pair in each 3L response level and the percentage of inconsistent pairs in each dimension.
The discriminative power of the two versions of the EQ-5D was assessed for their index scores and classification systems.
Relative Efficiency
The discriminative power of the two EQ-5D indices was assessed according to their index scores' relative efficiency (RE) in differentiating patients with T2DM differing in health severities. RE was defined as the ratio of F statistics of analysis of variance tests of the difference in the index scores between the two comparison groups of subjects known to differ in health. Because a higher Fstatistic value is more likely to result in statistical significance, the index score with a higher F-statistic value would be considered as more discriminative. In the study, we used the F-statistic value of the 3L index score to be the reference (RE ¼ 1) to calculate the RE of the 5L index score. Because patients with a clinical condition tend to have worse health than do patients without the condition, RE of the two EQ-5D index scores was assessed for patients with and without each of eight clinical conditions. The conditions included microvascular complications (i.e., retinopathy, neuropathy, and dermopathy), macrocomplications (i.e., ischemic heart disease, cerebrovascular disease, and peripheral vascular disease), any complications, two or more complications, three or more complications, any comorbidities, BMI levels of 25 or more, and hemoglobin A 1c (Hb A 1c ) levels of 6.5% or more.
Classification Efficiency
The classification efficiency of the EQ-5D dimension scales was assessed using the Shannon index (H') and the evenness index (J') [19, 20] . H' is defined as follows:
where L is the number of descriptive levels of a dimension scale and p i is the proportion of observations in the ith level
The 3L and the 5L have three and five descriptive levels, respectively. Larger H' values indicate higher classification efficiency. In the case of an even (rectangular) distribution (i.e., all levels are equally filled), H' reaches its maximum that equals log 2 L, which amounts to 1.58 to the 3L (i.e., log 2 3) and 2.32 to the 5L (i. e., log 2 5). J' is calculated as J' ¼ H'/H' max , indicating the usage of the system (H') given its inherent capacity (H' max ). The 95% confidence intervals for H' were estimated using a nonparametric bootstrap method with replacement strategy. The classification efficiency was also evaluated in terms of ceiling effects, described as the proportion of "no problem" responses in each dimension and in all dimensions. Reduction in ceiling effects suggests enhanced classification efficiency. We calculated the absolute reduction and relative reduction ([Ceiling3L À Ceiling5L]/Celing3L) in ceiling effects from the 3L to the 5L.
Results
A total of 121 patients with T2DM provided data for this study. The mean age of the patients was 55.5 Ϯ 12.7 years, of whom 57.0% were men. Many patients (59.5%) reported having one or more complications, with the prevalence ranging from 6.6% (diabetic amputation) to 31.4% (retinopathy) ( Table 1) . Most of the patients did not have any other comorbidities (57.9%); many patients had a BMI level of 25 (62.0%) or more and an Hb A 1c level of 6.5% (77.0%) or more.
There were 21 and 42 3L and 5L health states, respectively, observed in the study. The mean 3L and 5L index scores were 0.786 Ϯ 0.299 and 0.795 Ϯ 0.278, respectively. For preference scores between 0 and 0.7 (approximately), and at 1.0, more health-state observations were made in the 3L than in the 5L (Fig. 1) . The mean 3L score was higher than the mean 5L score for patients with a clinical condition and lower than the 5L score for patients without a clinical condition. The mean differences were 0.005 and À0.011, respectively ( Table 2 ). The exception was for patients with and without any comorbidities, for which the 3L score was lower than the 5L score (0.726 vs. 0.755) for patients with the condition and higher than the 5L score (0.830 vs. 0.817) for those without the condition.
The distributions of the 3L and the 5L dimension responses and the redistribution properties from the 3L to the 5L are presented in Table 2 . Most participants did not select the levels corresponding for "severe" or "extreme" problems no matter which version of the EQ-5D was used. The percentage of the 5L levels (i.e., levels 1, 3, and 5) decreased compared with that of the 3L levels in all the dimensions, suggesting the benefit of the added levels in the 5L. When going from the 3L to the 5L, the proportion in 5L-1 was always higher than the proportion in 5L-2 in each 3L-1 subgroup (range 69.6% [pain/discomfort] to 96.3% [anxiety/depression]). Similarly, the most frequent response was 5L-2 in all the 3L-2 subgroups. The 3L-3 subgroups had only a few observations and 5L-4 was mostly frequently observed. The proportion of inconsistency was low in all the dimensions, ranging from 2.5% (anxiety/depression) to 4.1% (usual activities).
The mean RE of the 5L scores of the eight clinical conditions was 1.87. Among these, the 5L scores were more efficient in seven of the eight conditions (range 1.11 [macrocomplications] to 4.00 [Hb A 1c Z 6.5%]). It was less efficient in differentiating between patients with and without any comorbidities (RE 0.81) ( Table 3) .
Compared with the 3L system, the 5L system had a substantial gain in classification efficiency in each dimension, indicated by higher H' values: mobility (1.17/0.70), self-care (0.57/0.40), usual activities (1.02/0.72), pain/discomfort (1.47/1.02), and anxiety/ depression (1.36/1.10). However, the degree of the use of system potential was comparable between the two systems, suggested by similar J' values of the two systems (Table 4) .
For both the EQ-5D classification systems, the self-care dimension showed the highest ceiling effects (3L: 91.7%; 5L: 88.4%), whereas the pain/discomfort dimension exhibited the lowest (3L: 62.0%; 5L: 57.0%). Ceiling effects reduced in all dimensions when moving from the 3L to the 5L (Table 5 ). The mobility dimension showed the largest reduction-the absolute and relative reductions were 7.4% and 9.0%. The proportion of "no problem" responses in all the dimensions decreased from 47.9% to 38.8%, indicating an absolute reduction of 9.1% and a relative reduction of 19.0% of the overall ceiling effects (Table 6 ).
Discussion
We found that the EQ-5D-5L is more discriminative than the EQ-5D-3L in patients with T2DM in Singapore. Its index score was more efficient in discriminating patients with different severity levels, and its classification system empirically described generic health in greater detail and reduced ceiling effects. The findings were in line with findings from the study based on a sample of Chinese patients with T2DM [15] , though the degree of superiority of the EQ-5D-5L in our study tended to be lower. The mean RE of the 5L index score was 1.87 versus 1.92 of the 3L index score. The absolute and relative reductions in ceiling effects were 9.1% and 19.1% versus 20% and 35.3%. Meanwhile, our sample had lower EQ-5D index scores: the mean 3L and 5L scores were 0.786 and 0.795 in comparison with 0.898 and 0.876 from the study in China. This may be due to two reasons. First, the Singapore EQ-5D-3L value set generated lower preference scores [17] . Second, our sample had worse health-related quality of life, suggested by lower percentages of "no problem" responses in all the EQ-5D dimensions.
Consistent with previous studies, the redistribution data showed skewed distributions in all dimensions [8] [9] [10] [11] [12] [13] . The 3L-1 and 5L-1 response pair always showed the largest proportion, because many patients with T2DM displayed no symptoms on a particular dimension no matter how refined the response scale was. The proportions of the 3L-2 and 5L-2 and the 3L-3 and 5L-4 response pairs were also large, supporting the inclusion of a second level and a fourth level for the 5L. It also implies that 
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Fig. 1 -Cumulative percentage of the EQ-5D-5L and EQ-5D-3L index scores. Table 2 -Response distributions of the EQ-5D-3L and the EQ-5D-5L, and redistribution properties of consistent and inconsistent responses from the EQ-5D-3L to the EQ-5D-5L..
Inconsistencies,* n (%) EQ-5D, EuroQol five-dimensional questionnaire; EQ-5D-3L (3L), three-level version of the EQ-5D; EQ-5D-5L (5L), five-level version of the EQ-5D. * An inconsistent response pair was defined as a 3L response that was at least two levels away from the 5L response (e.g., level 1 in the 3L and level 3 in the 5L); the other pairs were regarded as consistent.
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"some" or "extreme" problems in the 3L are better described by "slight" or "severe" problems in the 5L, respectively. The low proportion of inconsistent responses in all the dimensions meant that the participants could consistently use the two EQ-5D systems.
The finding that the 5L index score was more discriminative is expected because the score is related to its classification system, which defines health in much greater detail than does the 3L system. The finding is also similar to a previous study that compared the RE of the crude summary scores of the two versions of the EQ-5D in patients with cancer with different severities and showed that the 5L summary score was more efficient [10] . Moreover, our study systematically assessed the property through comparing the two EQ-5D indices in patients with and without various clinical conditions. Hence, the study provides an important evidence for using the 5L in patients with diabetes. The much higher RE (on average 1.87) suggested that adopting the 5L to capture a known health difference would significantly reduce the sample size requirement compared with using the 3L.
In general, the 3L index score was higher than the 5L index score if a clinical condition was present and it was lower than the 5L index score if a condition was absent. The reason for the former could be the reduction in ceiling effects from the 3L to the 5L; for the latter, it could be the fact that the patients perceived their health as less severe than the 3L described, because the observations of the 5L score between 0 to approximately 0.7 were less than those of the 3L score (Fig. 1 ). This systematic difference implies that the two EQ-5D indices would lead to different results in quantifying between-group differences or within-group Table 3 -Mean EQ-5D-3L and EQ-5D-5L index scores of patients with T2DM with and without a clinical condition.
Conditions (N)
Patients BMI, body mass index; EQ-5D, EuroQol five-dimensional questionnaire; EQ-5D-3L (3L), three-level version of the EQ-5D; EQ-5D-5L (5L), five-level version of the EQ-5D; RE, relative efficiency; Hb A 1c hemoglobin A 1c ; T2DM, type 2 diabetes mellitus. * Reference is 3L index score; an RE larger than 1 indicates that the EQ-5D-5L score is more discriminative. Table 5 -Classification efficiency of the EQ-5D-3L and the EQ-5D-5L classification systems measured by Shannon index (H'). CI, confidence interval; EQ-5D, EuroQol five-dimensional questionnaire; EQ-5D-3L (3L), three-level version of the EQ-5D; EQ-5D-5L (5L), fivelevel version of the EQ-5D. * Larger H' value indicates higher classification efficiency.
changes. The utility gain from a transition from with a condition to without the condition would be greater using the 5L index score. For example, according to our results, the gain from a transition from a BMI level of 25 or more to a BMI level of less than 25 would be 0.104 and 0.151 using the 3L and the 5L scores, respectively. This means a health intervention or program achieving such an improvement in health would be considered more efficient (e.g., more quality-adjusted life-years gained) using the 5L score than using the 3L score. Nevertheless, future studies should further examine this when the Singapore 5L value set derived from a valuation study is available.
The improved classification efficiency of the 5L was consistent with previous studies and was anticipated because the 5L classification system better described the health variations. However, the degree of improvement was varied. For example, the absolute and relative reductions in overall ceiling effects ranged from 1.1% to 12.6% and from 7.1% to 49.0%, respectively [8] [9] [10] [11] [12] [13] . It is not surprising because different populations have different health-related quality of life.
The study had several limitations. First, the 5L index scores were mapped from the 3L index scores because the Singapore 5L value set estimated from a valuation study had not yet been developed. Hence, the results may have been different if such a value set had been available. Second, only outpatients with T2DM joined the study. The findings may not be generalizable to inpatients with T2DM who may have more severe health problems. Third, the 5L was administered first, which might have introduced an order effect. Fourth, there may be a recall bias because the information of complications and comorbidities was recalled by patients themselves.
In conclusion, the EQ-5D-5L is more efficient than the EQ-5D-3L in detecting health variations. Findings from the study support the use of the EQ-5D-5L in patients with diabetes in Singapore.
Source of financial support: This study was supported by the National Healthcare Group of Singapore. EQ-5D, EuroQol five-dimensional questionnaire; EQ-5D-3L (3L), three-level version of the EQ-5D; EQ-5D-5L (5L), five-level version of the EQ-5D. * Relative reduction was defined as ([Ceiling3L À Ceiling5L]/Celing3L) in ceiling effects from the EQ-5D-3L to the EQ-5D-5L.
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